1 CAM -1 region was identified that conferred enhanced expression of CAT in HDMEC and suppressed expression of CAT in A431. This same region further enhanced CAT expression in transfected HDMEC treated with IL-la, yet no such enhancement was seen with IL-l treatment of identically transfected A431. However, treatment of A43l transfectants with IFNy did result in enhanced CAT expression, demonstrating reversal of A43l cell context suppression of the ICAM-l-based reporter gene construct. These data implicate the existence of both tissue-and cytokine-specific responsive elements in the 5' flanking region of the ICAM-l gene and demonstrate that regulatory effects directed by such elements are dependent upon their cellular context. Moreover, they provide the basis for identification of specific cisacting genetic elements, the trarls-acting factors with which they interact, and the molecular mechanisms by which they regulate transcription of the ICAM-l gene.] Invest Dermatol 100: [753] [754] [755] [756] [757] [758] 1993 expressed on all leukocytes, as well as Mac-l, which is expressed on neutrophils and monocytes [6 -13] ; both LFA-1 and Mac-1 are members of the integrin fJ2 subfamily of adhesion molecules. The coordinated expression and/or induction of CAMs SlIch as ICAM-1 allows leukocytes to bind to endothelial cells at sites of inflammation. Other CAMs that are also involved in the initialleukocyte-endothelial cell interaction include P-selectin (also known as GMP-140) [14, 15] , E-selectin (also known as ELAM-1) [16, 17] , and vascular cell adhesion molecule-1 (VCAM-1) [18, 19] . The regulated induction of these CAMs, which are not constitutively expressed on the endothelial cell-surface, in concert with upregulated expression of ICAM-1, allows not only initial leukocyte binding, but also transmigration into the tissue, and subsequent interaction with specific target cells, such as HK.
In addition, specific cytokines are capable of differentially regulating ICAM-1 expression on endothelial cells, HK, and other cells. Treatment of human dermal microvascular endothelial cells (HDMEC) ill vitro with interferon y (IFNy), tumor necrosis factor (TNFa), or interleukin 1 (IL-l) results in increased ICAM-1 cell surface and mRNA expression [20] . Induction ofICAM-l on HK, which do not constitutively express this CAM, o. ccurs afte~ treatment with either IFNy or TNFa [21] , but not WIth IL-1 stlmulation. Therefore, two cell types, HK and HD~C, demonstrate tissue-specific and cytokine-specific differences WIth respect to constitutive and induced ICAM-l expression. HK and HDMEC are known to be active participants, as well as targets, in cutaneous 0022-202X/93/S06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc. 753 inflammatory and immunologic processes. Thus, the delineation of precise molecular mechanisms that regulate tissue-specific and cytokine-specific expression ofICAM-l in these cells is important to our understanding of the cutaneous immunologic and inflammatory response. Our laboratory has recently isolated and characterized a human genomic clone that contains the 5' regulatory region of the ICAM-l gene [22] . Utilizing specific portions of this genomic clone, we have examined ill vitro the transcriptional regulation of the ICAM-l gene with regard to tissue-specific and cytokine-specific signals in HDMECs and A431, a human squamous cell carcinoma cell line, and herein present data that correlate the differential expression profiles seen ill vivo with distinct regulatory regions of this gene.
MATERIALS AND METHODS
Cell Culture HDMEC were isolated as previously described from neonatal foreskins, utilizing trypsinization and Percoll gradient centrifugation [23] . Characterization and analysis for £urity was performed through staining for von Willebrand factor (factor VIII -associated antigen) and uptake of acetylated LDL. The cells were maintained through s~quential passages, and typically utilized in passages 3,-6. Cells were grown in Endothelial Cell Basal Media (Clonetics Corp., San Diego, CA), supplemented with 30% normal human serum (Irvine, Santa Anna, CA), 2 mM L-glutamine (Irvine), 5 X 10-4 M cAMP (Sigma Chemical, St. Louis, MO), 1 Ilg/ml hydrocortisone acetate (Sigma), 5 ng/ml epidermal growth factor (Clonetics), and an antibiotic cocktail of 100 U Iml streptomycin, 100 U/ml penicillin, 251lg/ml amphotericin B (Irvine), and 10 Ilg/ml ciprofloxin (Miles Pharmaceuticals, West Haven, CT). Human umbilical vein endothelial cells (HUVEC) were isolated from umbilical veins treated with collagenase as previously described [24] . The cells were sequentially passaged and typically utilized in passages 3-8. Cells were cultured and maintained in Medium 199 (GIBCO, Grand Island, NY) supplemented with 20% fetal bovine serum, 100 Ilg1 ml endothelial cell growth supplement (Biomedical Te.chnologies, Stoughton, MA), 50 Ilg/ml heparin, 2 mM L-glutamme, and 100 U/ml streptomycin, 100 U/ml penicillin, 250 Ilg/ml amphotericin B. A431 were obtained from American Type Culture Collection (Rockville, MD) and were cultured in Dulbecco's modified Eagle's medium (4.5 gil glucose) (GIBCO) supplemented with 3 mM L-glutamine, 10% heat-inactivated fetal bovine serum, 100 U I ml penicillin, 250 Ilg1 ml amphotericin B, and 100 Ilg/ml streptomycin.
Reagents and Cytokines Specific reagents and their sources included recombinant human IFNy (Amgen Biologicals, Thousand Oaks, CA) and human IL-la (Biologic Response Modifiers Branch, NCI, NIH, Frederick, MD). Dosage and treatment intervals were determined by previous experiments with the cytokine-responsiveness of A431 and HDMEC ill vitro.
Transfections and Assays of Activity of ICAM-l-Based Chloramphenicol-Acetyl Transferase (CAT) Reporter Gene Constructs Isolation and characterization of the 5' portion of the human ICAM-l gene by our laboratory has been previously described [22] . The exon/intron organizational structure of this 17.3kb genomic clone, the 2.05-kb subfragment that contains the immediate 5' flanking region, and the ICAM-l -based CAT reporter gene constructs utilized in these studies are schematically shown in Fig 1. The 2.05-kb subfragment contains the transcription initiation site, first exon, a portion of the first intron, and 1350 bp of 5' flanking region. Restriction endonuclease sites were utilized to create several specific fragments, which were introduced into CAT reporter gene constructs [22] . The 282-bp Hil1dIIl/SstI fragment, designated HS, extending 277 bp 5' of the transcription start site, was subcloned into a promoterless CAT expression vector, pCAT-Basic (Promega, Madison, WI), resulting in construct pHS-CAT.
pBS-CAT was constructed with the 1165 Bg III I SstI (BS) fragment THE JOURNAL OF INVESTIGATIVE DERMATOLOGY of the genomic ICAM-1 subclone and contains the region of the HS fragment, as well as an additional upstream 883 bp of the 5' flanking region. pBH-CAT contains the 883 upstream BglII/HilldIlI (BH) fragment, but does not include the immediate 5'f1anking region contained in the HS fragment. pCAT-Control (pCAT-C, Promega), which contains the SV 40 promoter and enhancer, served as a positive control for CAT expression, and pCAT -Basic (pCAT-B, Promega), which contains no promoter or enhancer, served as a negative control for CAT expression. Subconfluent A431 cell cultures (10 6 cells/75 cm 2 tissue culture dish) were transfected by the calcium phosphate precipitation technique [25] with 10 Ilg plasmid DNA utilizing techniques and procedures as previously described [22] . Subconfluent HDMEC cultures (5 -7.5 X 10 5 cells/75 cm 2 tissue culture dish) were also transfected by this technique; however, these cells proved to be more sensitive to this procedure. Therefore, varying treatment regimens were employed in an attempt to minimize cell insult and optimize DNA transfection and expression. We established that transfection of earlier-passage HDMEC, plated at near-confluence, with a 6-8-h exposure to the plasmid DNA/calcium phosphate precipitant, resulted in better cell viability and higher reporter gene expression. Sixteen to twenty-four hours after transfection and replenishment with appropriate media, transfectants were exposed to selected cytokines for 18-24 h prior to preparing cellular lysates for CAT analysis. Lysates were prepared as previously described [22] . IFNy was utilized at 250 U/ml; IL-la was utilized at 80 U Iml. Protein concentration of celllysates were determined spectrophotometrically [25] , and Iysates were normalized for protein concentration prior to assay. Previous studies had established that the constructs utilized displayed near identical transfection efficiencies within any given cell type. Cell Iysates were assayed for CAT enzyme expression as previously described [22] using HC-Iabeled chloramphenicol (Amersham Corp., Arlington Heights, IL) as substrate. Chloramphenicol and acetylated derivatives were resolved by thin-layer chromatography, and percent conversions of substrate to acetylated forms were determined via scintillation counting of appropriate areas of the chromatograph after autoradiography was performed. 
RESULTS

The 5' Flanking Region of the ICAM-1 Gene Contains a
Functional, Potent Promoter when Transiently Transfected into HDMEC As previously reported, the 282-nucleotide HindIII/SstI fragment (HS) can function as a potent promoter of CAT expression in A431 cells [22] . In HDMEC as well, the inserted HS fragment functioned as a potent promoter when pHS-CAT was transiently transfected into these cells. Representative experiments in A431 and HDMEC are shown illustrating the autoradiography of CAT assays and calculated percent CAT conversion (Fig 2) . Neither the negative control pCAT-B (not shown), nor the construct driven by the 883-bp ICAM-1 upstream fragment (BH) , resulted in CAT expression in either cell type, demonstrating that this upstream region does not contain a functional promoter that is biologically operative within the cellular context of either A431 or HDMEC.
The 5' Flanking Region of the ICAM·1 Gene Demonstrates Differential Tissue-Specific Responsiveness when Transiently Transfected into A431 and HDMEC In multiple analyses, pHS-CAT resulted in CAT expression in both A431 and HDMEC (Fig 2) . However, the construct containing 1165-bp BS fragment (pBS-CAT) , which includes the basal promoter region contained in HS as well as the contiguous 883-bp upstream region, resulted in differential CAT expression when transfected into A431 and HDMEC (Fig 2) . In A431, conversion of1 4 C chloramphenicol to acetylated product following transfection with pBS-CAT was routinely lower than CAT expression seen with pHS-CAT, indi-TISSUE AND CYTOIUNE RESPONSIVENESS OF ICAM-I 755 cating the presence of a functional repressor element within the upstream region that was active within the A431 cellular context. Conversely , in HDMEC, pBS-CAT expression was routinely as great or greater than that seen with pHS-CAT, thus demonstrating no evidence within this endothelial cell context of an active upstream repressor. The possibility that the putative upstream repressor element, which was active when pBS-CAT was transfected into A431, was derepressed within HDMEC because of significant differences in culture conditions was investigated. A431 cells were cultured in HDMEC media and transfections were performed with pBH-CAT, pHS-CAT, and pBS-CAT. The repressor activity of the ICAM-1 5' flanking region of the BS fragment in A431 remained active in A431 cells cultured in HDMEC media as well (data not shown). Therefore, in A431, a human keratinocyte-like cell line, transfection of pBS-CAT resulted in decreased reporter gene expression as compared to pHS-CAT. In HDMEC, however, pBS-CAT demonstrated equivalent or increased expression of acetylated product. These results are analogous to ill villo ICAM-1 expression within these two different tissue contexts. The pBS-CAT construct contains a greater amount of the ICAM-l transcriptional regulatory region and its expression in HDMEC versus A431 is quite similar to the expression profiles of ICAM-1 as seen in endothelial cells and keratinocytes itl lIivo. That is, there is constitutive expression of ICAM-l in endothelial cells, and little to no expression in keratinocytes.
Enhancer Activity of the 5' Flanking Region of the ICAM-1 Gene Demonstrates Differential Cytokine Responsiveness that Is Cellular-Context Dependent Cytokine-specific responsiveness of the ICAM-l gene was studied through transfection of ICAM-1-hased reporter gene constructs into A431 or HDMEC followed by cytokine stimulation of the transfected cells. Parallel transfections with pBH-CAT or pCAT-B, pHS-CAT, and pBS-CAT were followed by cytokine stimulation with IL-1a (80 UI ml), or IFNy (250 U/ml) for 16-24 h prior to lysate preparation and CAT assays . Previous studies in our laboratories had established that these dosages and times of exposure were optimal for induction of expression of the endogenous ICAM-1 gene in both A431 and HDMEC. A431 transfected with pBS-CAT did not demonstrate increased CAT expression when treated with IL-1, as shown by continued low conversion rates of chloramphenicol to acetylated product (Fig 3) . However, A431 transfected with pBS-CAT did demonstrate enhanced responsiveness when treated with IFNy ( Fig  3) , indicating that upstream enhancers of the ICAM-1 gene are functional within A431 cells when transfectants are exposed to signals appropriate for these cells. The expression following IFNy was driven to a level greater than that seen with untreated pBS-CAT transfectants, and, in fact, greater than was seen with the potent pHS-CAT construct. Thus, similar to the failure of the endogenous ICAM-1 gene within keratinocytes and A431 cells to respond to IL-1 stimulation of these cells, ICAM-1-based reporter gene constructs did not display enhanced expression in response to IL-1 stimulation when transfected into a keratinocyte-like cellular context.
In contrast to keratinocytes and A431, HDMEC consti~tively express higher levels of ICAM-l and have been shown to l~crease ICAM-1 expression after IL-l stimulation. Similarly, IL-l stimulation ofHDMEC transfected with pBS-CAT, in contr~st to :'-431 cells, lead to markedly increased reporter gene expressIOn (Fig 4) . No enhancement of CAT expression was evident following IL-1 treatment of cells transfected with the pHS-CAT construct. Fo~r similarly performed experiments in HDMEC are shown graphically in Fig 5, and demonstrate that IL-1-indllced enhancement of CAT expression is seen only with the larger pBS-CA~ const.ru~t, indicating that an IL-1 responsive element is not contall1ed wl~I~1Il the small er HS fragment. Experiments were also performed Utlltzing large-vessel endothelial cells (HUVEC), which in vitro constitutively express ICAM-1 and upreglliate ICAM-l in response to IL-1, as well. IL-1 -induced enhanced CAT expression was observed Figure 3_ Cytokine responsiveness of ICAM-l-based CAT constructs transiently transfected into A431 cells. Representative experiment illustrating relative transcriptional activity of specific ICAM-l-based CAT plasmids transiently transfected into A431 cells and subsequently treated with the indicated cytokines. Transfectants were exposed to IL-la at a fina l concentration of80 U/ml for 16 h, orto IFNyat250 U/ml for 16 h, priorto lysate preparation. pHS-CAT did not show enhanced expression in response to IL-l, nor did negative (pCAT-Basic) or positive (pCAT-Control) pi asmids show enhanced expression with either cytokine (data not shown). The panels depict autoradiographic data, quantitation of percent CAT conversion, and constructs utilized as described in Fig 2. with the transfected pBS-CAT construct, but not with pHS-CAT, in these cells as well (data not shown) .
DISCUSSION
In these studies, we have utilized the 5' flanking region of the human ICAM-I gene to investigate the tissue-specific and cytokine-specific regulation of the ICAM-I gene within the cellular context of A43I and HDMEC. Using ICAM-I-based reporter gene constructs, we have identified a portion of the 5' regulatory region of the human ICAM-1 gene, located upstream to the basal promoter, that confers differential gene expression in two cell types. Transfections with constructs containing this region confer repressed expression in A431, as previously reported [22] . and enhanced expression of the gene in HDMEC, as presently shown. Interestingly, when using the pBS-CAT construct, which as the largest, more inclusive construct utilized more closely approximates the wild type biologic situation, expression and responsiveness of the reporter gene product was analogous to expression of the endogenous ICAM-I gene within each in vivo cellular context. That is, expression profiles of the reporter gene product reflected the expression of ICAM-1 in each cell type. A431 constitutively express ICAM-1 at very low levels, and transfection with the pBS-CAT construct resulted in decreased gene expression, demonstrating constitutive repressor activity within this cellular context. In contrast, transfection of pBS-CAT into HDMEC demonstrated increased expression of the reporter gene product, and these cells constitutively express ICAM-1 at higher levels in vitro and in vivo.
The shorter pHS-CAT construct was expressed well in both cellular contexts, demonstrating the biologic functionality and potency of Figure 4_ Cytokine responsiveness of ICAM-l-based CAT constructs transiently transfected into HDMEC. Representative experiment illustrating relative transcriptional activity of specific ICAM-l -based CAT plasmids transiently transfected into HDMEC and subsequently treated with IL-l. Transfectants were exposed to IL-1a at a final concentration of 80 U/ml for 16 h prior to lysate preparation. There was no enhancement of positive control plasmid (pCAT -Control) expression following IL-1a stimulation (data not shown). The panels depict autoradiographic data, quantitation of percent CAT conversion, and constructs utilized as described in Fig 2. the basal promoter contained within the HS fragment. Studies utilizing the pHS-CAT construct also indicate that the regulatory regions and cis-elements required for both tissue-specific repression, as seen with transfections into A431 cells, and IL-1 enhancement, as seen with transfections into HDMEC, are not contained within the HS fragment but reside within the larger 883-bp upstream BH fragment.
Using investigative approaches similar to those utilized in these studies, the tissue-specific regulation of the rat insulin gene in pancreatic and non-pancreatic cells has been studied by Nir et al [26] . These researchers hypothesized that tissue-specific regulation of insulin gene expression was dependent upon the differential expression and activity of both negative and dominant trans-acting factors that either repressed or promoted insulin gene expression, depending upon cellular context. These researchers demonstrated that the activity of a rat insulin gene enhancer was acted upon by a negative trans-acting factor present in non-insulin expressing cells, and that the activity of such a repressor factor was suppressed by a dominant trans-acting factor present in insulin-producing cells. Likewise, Junker et al [27] have studied immunoglobulin production in Bcell/fibroblast hybrids and have described the absence in fibroblasts of a B-cell-specific transcription factor that is necessary for immunoglobulin gene expression. Our current work, buttressed by findings such as these, illustrates that the differential expression of the ICAM-1 gene is dependent upon the molecular interaction of specific regions of the ICAM-1 gene, which is identical within all cells, with factors that are differentially expressed and induced within different cellular contexts.
Utilizing the 5' regulatory region of the ICAM-I gene, our laboratory has demonstrated that a specific region of this gene, contained within the I165-bp BS fragment, contains not only the basal promoter region, but also a functional IL-I responsive region that 2r-------------------------------~~ HDMEC transfectants were treated with IL-1a at 80 U/ml for 16 h prior to lysate preparation and CAT assay. T he relative conversion of 14C-labeled chloramphenicol to acetylated product is depicted along the Y axis (± SEM), with conversion rates normalized to a percent conversion value for untreated pBS-CAT expression arbitrarily set at a value of 1 (n = 4 for treated and untreated pCAT-Basic, pBS-CAT, and untreated pHS-CAT; n = 3 for ILl-treated pHS-CAT). rCAM-l-based and control CAT reporter gene constructs utilized are indicated along the x axis.
can be activated within the cellular context of endothelial cells, but cannot be activated within the context of keratinocyte-like cell lines, such as A431. A431 cells have been found to have similar induction profiles as HK for expression of ICAM-l [28] ; IL-l stimulation does not induce ICAM-1 expression in either cell type. However, HK and A431 are known to express IL-l receptors (II-lr) [29] . It has recently been demonstrated that HK constitutively produce IL-l receptor antagonist (IL-l raj [30] that is capable of interacting with the IL-1 receptor. Occupancy of the IL-1r with IL-1ra does not resu lt in cell activation, but rather acts as a competitive inhibitor of IL-l stimulation [31] . Within the context of our studies, occupation of A431 or HK IL-lr by IL-1ra may, in fact, preclude sufficient IL-1 activation of these cells and the subsequent induction of secondary signals that are required for enhancement of ICAM-1 gene expression within this cellular context. Although such a mechanism with regard to ICAM-1 expression ~ at present speculative, the differential cytokine responsiveness demonstrated in these experiments is again analogous to the in vivo cellular situation. The cytokine responsiveness of many genes has been linked to the activation and/or induction of numerous second messengers [32] , trans-acting factors [33, 34] ' and protooncogenes [35] . In human fibroblasts, IL-l and TNFa induction of the IL-6 gene has been mapped to a 5' portion of this gene; the cis-element in this gene that was both necessary and sufficient for IL-1-induced enhancement was found to contain a sequence homo logous to an NFKB-like element [33] . In addition, Osborn et al [36] characterized TNFa and IL-1 induction of the human immunodeficiency virus enhancer by activation of the trans-acting factor NFKB. Finally, Colotto et al [35] have characterized the induction of another trallSacting factor, c-fos, in HUVEC following IL-1 stimulation. This &ctor, in concert with another oncogene product, c-jun, forms a potent, heterodimeric trallsactivating protein that binds to the consensus cis-element sequence designated AP-1. Both consensus AP-1 and NFKE binding sites are located within the 883-bp upstream region (EH) of the ICAM-1 gene, and these studies have demon-Itrated that this region is required for the functional regulation of ICAM-l expression in response to specific signals. Thus, there are several candidate trails-acting factors and consensus cis-elements that may be involved in both tissue-specific repression and IL-1induced enhancement of ICAM-l gene expression.
In conclusion, these findings provide the basis for identification of specific cis-acting genetic elements within the 5' flanking region TISSUE AND CYTOKlNE RESPONSIVENESS OF ICAM-I 757 of the human ICAM-1 gene that dictate the level of gene transcription in response to both cellular context and IL-1 stimulation. Characterization of tissue-specific and cytokine-specific elements within the ICAM-1 gene will allow identification of the tram-acting factors mediating these regulatory events. Deletional analysis is currently underway to determine whether previously characterized or other as yet undefined elements and factors are critical to either the tissue-specific or cytokine-specific regulatory responses of the ICAM-1 gene that we have observed.
